Category Archives: Depakote

Featured Stories
Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

$15 Million in Damages Awarded to Child for Birth Defects Linked to Depakote

$15M Awarded to Child for Defects Linked to Depakote

This week a St. Louis jury found that a Minnesota girl’s birth defects were caused by the epilepsy medication Depakote her mother took during pregnancy and the jury awarded the child $15 million in damages. The jury returned the unanimous … Continue reading

Posted in Birth Defects, Depakote, Legal News, Pharmaceuticals | Tagged , , , , |

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

British Health Agency Strengthens Warnings about Valproate

The Medicines and Healthcare Products Regulatory Agency (MHRA), Britain’s drug regulatory agency, has issued a statement urging healthcare professionals to give women better information on the risk of birth defects when Depakote and other valproate medicines are used during pregnancy. … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Epilepsy Medications Tied to Additional Fetal Risks

epilepsy_medications_fetal_risks

An emerging study has found that anti-epileptic drugs—AEDs—contain additional risks to developing fetuses to those on current drug product labeling. AEDs include the brands Tegretol, Carbatrol, Equetro, Epitol, Lomotrigine, and Depakote. The active ingredient in Depakote is valproate. The Danish … Continue reading

Posted in Depakote, Pharmaceuticals |

Study: Reducing Valproate Dose Could Help Minimize Some, Not All, Birth Defects

valporate_specific_birth_defects

Valproate-containing epilepsy drugs have long been linked to serious adverse health effects, including risks of babies being born with birth defects. Depakote is a valproate-containing medication. For instance, while use of epilepsy medications during pregnancy has been associated with congenital … Continue reading

Posted in Depakote, Pharmaceuticals |

Abbott Labs Accused of Racketeering in Depakote Marketing

abbott_acused_of_racketeering

A federal court complaint filed in U.S. District Court in Chicago alleges that Abbott Laboratories engaged in racketeering when it marketed the epilepsy drug Depakote (divalproex) for unapproved uses. The plaintiffs—the Sidney Hillman Health Center of Rochester, New York; the … Continue reading

Posted in Depakote, Pharmaceuticals |

Judge Rules Abbott Can be Sued for Off-label Depakote Sales

Depakote_Off_Label_Sales

U.S. District Judge Virginia Kendall recently upheld a shareholder derivative complaint against Abbott Laboratories for its off-label marketing of the drug Depakote. Physicians are allowed to prescribe drugs for off-label uses, but drug companies are not permitted to market drugs … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Legal News, Pharmaceuticals |

FDA: Migraine Medication, Depakote, May Lower IQ Scores in Children

Depakote_Lower_IQ

United States regulators are warning pregnant women who also suffer from migraine headaches that Depakote may lower a child’s IQ score by eight to 11 points. Depakote is being changed from a Category D to a Category X drug classification. … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA Warns Pregnant Women: Do Not Take Valproate Containing Migraine Prevention Drugs During Pregnancy

Valproate_Pregnancy_FDA-Warning

The U.S. Food and Drug Administration (FDA) has issued a warning to pregnant women against using valproate sodium products, prescribed for migraine prevention, over risks to their unborn babies. Valproate products include Depacon (valproate sodium); Depakote, Depakote CP, and Depakote … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA: Seizure Drug, Potiga, Associated with Vision Loss, Blue Skin

Anti-seizure medication, Potiga, co-marketed by GlaxoSmithKline Plc and Valeant Pharmaceuticals, may lead to optical and skin problems, the U.S. Food and Drug Administration (FDA) has said. Potiga, which was developed by Valeant, may cause skin to turn blue around the … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.